UDC

616.89-008.48-053.2

Authors

Suvorinova Natalya Yuryevna, The Russian National Research medical University named after N.I. Pirogov (Moscow, Russia) 

Abstract

The paper dwells on conditions comorbid to attention deficit hyperactivity disorder (ADHD), which are observed in at least 70 % of patients and lead to additional problems in family life, school education and psychosocial adaptation. Such comorbid disorders as oppositional defiant disorder, different anxiety disorders, tics and nocturnal enuresis may be present in many children and adolescents suffering from ADHD. The treatment of ADHD should be long enough and be planned taking into account both the core ADHD symptoms and comorbid disorders. When choosing pharmacotherapy, preference should be given to the medicines having as monotherapy a positive effect on both the core symptoms of ADHD and comorbid emotional, behavioral and other disorders. From this point of view, we considered the therapeutic action of atomoxetine hydrochloride, adaptol and tenoten.

Keywords

attention deficit hyperactivity disorder, comorbidity, diagnosis, pharmacotherapy.

References

1. Barkley R.А. Defiant Children: A Clinician’s Manual for Assessment and Parent Training, and Child Psychopathology. 2nd ed. New York (Russ. ed.: Barkli R.A. Deti s vyzyvayushchim povedeniem. Klinicheskoe rukovodstvo po obsledovaniyu rebenka i treningu roditeley. Мoscow, 2011. 272 p.). 
2. Gromov L.A., Dudko E.T. “Tipichnye” i “atipichnye” trankvilizatory [“Typical” and “Atypical” Tranquilizers]. Vestnik farmakologii i farmatsii, 2003, no. 10, pp. 11−17. 
3. Zavadenko N.N., Solomasova A.A. Sindrom defitsita vnimaniya s giperaktivnost’yu v sochetanii s trevozhnymi rasstroystvami: vozmozhnosti farmakoterapii [Attention Deficit Hyperactivity Disorder with Comorbid Anxiety Disorders: Pharmacotherapy Options]. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova, 2012, vol. 112, no. 8, pp. 44−48. 
4. Zavadenko N.N., Suvorinova N.Yu. Komorbidnye rasstroystva pri sindrome defitsita vnimaniya s giperaktivnost’yu u detey [Disorders comorbid to Attention Deficit Hyperactivity Syndrome in Children]. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova, 2007, vol. 107, no. 7, pp. 39−44. 
5. Zavadenko N.N., Suvorinova N.Yu. Sindrom defitsita vnimaniya s giperaktivnost’yu: poisk optimal’nykh podkhodov k diagnostike i lecheniyu [Attention Deficit Hyperactivity Disorder: Searching for the Best Approaches to Diagnosis and Treatment]. Effektivnaya farmakoterapiya v nevrologii i psikhiatrii, 2010, no. 4, pp. 34−39. 
6. Chutko L.S., Surushkina S.Yu., Yakovenko E.A., et al. Kliniko-psikhofiziologicheskaya kharakteristika detey podrostkov s khronicheskimi tikami [Clinical and Psychophysiological Characteristics of Children and Adolescents with Chronic Tics]. Vestnik Severnogo (Arkticheskogo) federalnogo universiteta. Ser.: Mediko-biologiheskie nauki, 2013, no. 1, pp. 91–99. 
7. Chutko L.S., Aybekov K.A., Lapshina O.V., et al. Komorbidnye trevozhnye rasstroystva pri sindrome defitsita vnimaniya s giperaktivnost’yu [Comorbid Anxiety Disorders in ADHD Children]. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova, 2008, vol. 108, no. 3, pp. 49−52. 
8. MKB-10 − Mezhdunarodnaya klassifikatsiya bolezney (10-y peresmotr). Klassifikatsiya psikhicheskikh i povedencheskikh rasstroystv. Issledovatel’skie diagnosticheskie kriterii [ICD-10 – International Statistical Classification of Diseases and Related Health Problems (10th Revision). Classification of Mental and Behavioral Disorders. Research Diagnostic Criteria]. St. Petersburg, 1994. 208 p. 
9. Retyunskiy K.Yu., Petrenko T.S. Poisk novykh vozmozhnostey effektivnoy i bezopasnoy terapii giperkineticheskogo rasstroystva u detey [Searching for New Ways of Safe and Efficient Treatment for Hyperkinetic Disorder in Children]. Akademicheskiy zhurnal Zapadnoy Sibiri, 2010, no. 2, pp. 13−16. 
10. DuPaul G.J., Power T.J., Anastopoulos A.D., Reid R. ADHD Rating Scale–IV: Checklists, Norms, and Clinical Interpretations. N. Y., 1998. 80 p. 
11. Geller D., Donnelly C., Lopez F., et al. Atomoxetine Treatment for Pediatric Patients with Attention-Deficit/ Hyperactivity Disorder with Comorbid Anxiety Disorder. J. Am. Acad. Child. Adolesc. Psychiatry, 2007, vol. 46 (9), pp. 1119−1127. 
12. Milberger S., Biederman J., Faraone S.V., et al. Attention Deficit Hyperactivity Disorder and Comorbid Disorders: Issues of Overlapping Symptoms. Am. J. Psychiatry, 1995, vol. 152 (12), pp. 1793−1799. 
13. Barkley R.A. Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. 3rd ed. N. Y., 2005. 770 p. 
14. Diagnostic and Statistical Manual of Mental Disorders, 5th ed. (DSM-V). American Psychiatric Association. Washington, 2013. 947 p. 
15. Vloet T.D., Konrad K., Herpertz-Dahlmann B., et al. Impact of Anxiety Disorders on Attentional Functions in Children with ADHD. J. Affect. Disord., 2010, vol. 124 (3), pp. 283−290. 
16. Sørensen L., Plessen K.J., Nicholas J., Lundervold A.J. Is Behavioral Regulation in Children with ADHD Aggravated by Comorbid Anxiety Disorder? J. Atten. Disord., 2011, vol. 15 (1), pp. 56−66. 
17. Jarrett M.A., Ollendick T.H. A Conceptual Review of the Comorbidity of Attention-Deficit/Hyperactivity Disorder and Anxiety: Implications for Future Research and Practice. Clinical Psychology Review, 2008, vol. 28 (7), pp. 1266–1280. 
18. Spence S.H., Barrett P.M., Turner C.M. Psychometric Properties of the Spence Children’s Anxiety Scale with Young Adolescents. J. Anxiety Disord., 2003, vol. 17 (6), pp. 605−625. 
19. Tannock R. Attention-Deficit/Hyperactivity Disorder with Anxiety Disorders. Attention-Deficit Disorders and Comorbidities in Children, Adolescents, and Adults. Ed. by Brown T.E. Washington, 2000, pp. 125−170. 
20. Conners C.K., Sitarenios G., Parker J.D., Epstein J.N. The Revised Conners’ Parent Rating Scale (CPRS-R): Factor Structure, Reliability, and Criterion Validity. J. Abnorm. Child Psychol., 1998, vol. 26 (4), pp. 257–268. 
21. Weiss M.D., Wasdell M.B., Bomben M.M. Weiss Functional Impairment Rating Scale – Parent Report (WFIRS-P). BC Children’s Hospital, 2004. 10 p.